Sarcopenia encompasses the loss of muscle mass and strength/function during aging. Several methods are available for the estimation of muscle or lean body mass. Popular assessment tools include body imaging techniques (e.g., magnetic resonance imaging, computed tomography, dual X-ray absorptiometry, ultrasonography), bioelectric impedance analysis, anthropometric parameters (e.g., calf circumference, mid-arm muscle circumference), and biochemical markers (total or partial body potassium, serum and urinary creatinine, deuterated creatine dilution method). The heterogeneity of the populations to be evaluated as well as the setting in which sarcopenia is investigated impacts the definition of “gold standard” assessment techniques. The aim of this article is to critically review available methods for muscle mass estimation, highlighting strengths and weaknesses of each of them as well as their proposed field of application.

Tosato, M., Marzetti, E., Cesari, M., Savera, G., Miller, R. R., Bernabei, R., Landi, F., Calvani, R., Measurement of muscle mass in sarcopenia: from imaging to biochemical markers, <<AGING CLINICAL AND EXPERIMENTAL RESEARCH>>, 2017; 29 (1): 19-27. [doi:10.1007/s40520-016-0717-0] [http://hdl.handle.net/10807/164849]

Measurement of muscle mass in sarcopenia: from imaging to biochemical markers

Tosato, M.;Marzetti, E.;Cesari, M.;Savera, G.;Bernabei, R.;Landi, F.;Calvani, R.
2017

Abstract

Sarcopenia encompasses the loss of muscle mass and strength/function during aging. Several methods are available for the estimation of muscle or lean body mass. Popular assessment tools include body imaging techniques (e.g., magnetic resonance imaging, computed tomography, dual X-ray absorptiometry, ultrasonography), bioelectric impedance analysis, anthropometric parameters (e.g., calf circumference, mid-arm muscle circumference), and biochemical markers (total or partial body potassium, serum and urinary creatinine, deuterated creatine dilution method). The heterogeneity of the populations to be evaluated as well as the setting in which sarcopenia is investigated impacts the definition of “gold standard” assessment techniques. The aim of this article is to critically review available methods for muscle mass estimation, highlighting strengths and weaknesses of each of them as well as their proposed field of application.
Inglese
Tosato, M., Marzetti, E., Cesari, M., Savera, G., Miller, R. R., Bernabei, R., Landi, F., Calvani, R., Measurement of muscle mass in sarcopenia: from imaging to biochemical markers, <<AGING CLINICAL AND EXPERIMENTAL RESEARCH>>, 2017; 29 (1): 19-27. [doi:10.1007/s40520-016-0717-0] [http://hdl.handle.net/10807/164849]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/164849
Citazioni
  • ???jsp.display-item.citation.pmc??? 62
  • Scopus 139
  • ???jsp.display-item.citation.isi??? 136
social impact